CHAPTERS Group AG
F:CHG

Watchlist Manager
CHAPTERS Group AG Logo
CHAPTERS Group AG
F:CHG
Watchlist
Price: 40 EUR 1.27%
Market Cap: 781.9m EUR
Section:
 

Relative Value

The Relative Value of one CHG stock under the Base Case scenario is 39.04 EUR. Compared to the current market price of 40 EUR, CHAPTERS Group AG is Overvalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CHG Relative Value
Base Case
39.04 EUR
Overvaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.2
P/S
P/S
Price to Sales
7.2
vs History
47
vs Industry
15
Median 3Y
6.7
Median 5Y
7.1
Industry
2.4
Forward
5.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
0
Median 3Y
-50.9
Median 5Y
-40.5
Industry
22.9
Forward
-150.6
More Details
31
P/OCF
P/OCF
Price to OCF
31
vs History
36
vs Industry
6
Median 3Y
29.3
Median 5Y
29.3
Industry
14.7
More Details
17.5
P/FCFE
P/FCFE
Price to FCFE
17.5
vs History
47
vs Industry
Median 3Y
17.1
Median 5Y
17.1
Industry
21.4
More Details
4.2
P/B
P/B
Price to Book Value
4.2
vs History
6
vs Industry
15
Median 3Y
3.2
Median 5Y
2.6
Industry
2.3
More Details
7.2
EV/S
EV/S
Enterprise Value to Sales
7.2
vs History
46
vs Industry
14
Median 3Y
6.7
Median 5Y
6.9
Industry
2.6
Forward
5.4
More Details
8.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.6
vs History
7
vs Industry
20
Median 3Y
7
Median 5Y
5.1
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
3
Median 3Y
48.1
Median 5Y
-39.1
Industry
12.3
Forward
28.5
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-65.4
Median 5Y
-65.4
Industry
17.2
Forward
-161.4
More Details
31.1
EV/OCF
EV/OCF
Enterprise Value to OCF
31.1
vs History
34
vs Industry
6
Median 3Y
28.7
Median 5Y
28.7
Industry
15
More Details
36.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
36.4
vs History
47
vs Industry
6
Median 3Y
35.4
Median 5Y
35.4
Industry
19
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
60
vs Industry
24
Median 3Y
2
Median 5Y
1.7
Industry
1.9
More Details

Multiples Across Competitors

CHG Competitors Multiples
CHAPTERS Group AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
CHAPTERS Group AG
F:CHG
945.3m EUR 7.2 -50.7 -1 144.7 -32.5
US
Veeva Systems Inc
NYSE:VEEV
35.9B USD 11.7 41.7 31.6 33
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
21.6B AUD 97.8 187.1 129.2 129.2
JP
M3 Inc
TSE:2413
1.4T JPY 4.3 31.5 15.8 19.4
US
Doximity Inc
NYSE:DOCS
7.6B USD 12.2 30.3 25.9 27.1
US
Waystar Holding Corp
NASDAQ:WAY
5.2B USD 5 46.7 15.8 24.7
SE
Sectra AB
STO:SECT B
45.5B SEK 20 69.4 -137 -137
CN
Winning Health Technology Group Co Ltd
SZSE:300253
30.8B CNY 15.1 -100.1 -209 -209
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
292.1B INR 11 60.1 37.4 43.6
US
Heartflow Inc
NASDAQ:HTFL
2.9B USD 0 0 0 0
P/E Multiple
Earnings Growth PEG
DE
CHAPTERS Group AG
F:CHG
Average P/E: 65
Negative Multiple: -50.7 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
41.7
32%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
187.1
32%
5.8
JP
M3 Inc
TSE:2413
31.5
16%
2
US
Doximity Inc
NYSE:DOCS
30.3
18%
1.7
US
W
Waystar Holding Corp
NASDAQ:WAY
46.7
N/A N/A
SE
Sectra AB
STO:SECT B
69.4
17%
4.1
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -100.1
92%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
60.1
31%
1.9
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
CHAPTERS Group AG
F:CHG
Average EV/EBITDA: 39.6
Negative Multiple: -1 144.7
99%
N/A
US
Veeva Systems Inc
NYSE:VEEV
31.6
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
129.2
32%
4
JP
M3 Inc
TSE:2413
15.8
14%
1.1
US
Doximity Inc
NYSE:DOCS
25.9
23%
1.1
US
W
Waystar Holding Corp
NASDAQ:WAY
15.8
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -137 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -209
36%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
37.4
24%
1.6
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DE
CHAPTERS Group AG
F:CHG
Average EV/EBIT: 45.8
Negative Multiple: -32.5 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33
39%
0.8
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
129.2
31%
4.2
JP
M3 Inc
TSE:2413
19.4
N/A N/A
US
Doximity Inc
NYSE:DOCS
27.1
25%
1.1
US
W
Waystar Holding Corp
NASDAQ:WAY
24.7
58%
0.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -137 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -209
47%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
43.6
26%
1.7
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A

See Also

Summary
CHG intrinsic value, competitors valuation, and company profile.
DCF Valuation
CHG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CHG stock valuation using valuation multiples.
Wall Street Estimates
CHG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CHG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.